✦ LIBER ✦

Comparison of the in vitro effects of the anti-CD20 antibodies rituximab and GA101 on chronic lymphocytic leukaemia cells

✍ Scribed by Michaela Patz; Polina Isaeva; Nche Forcob; Bianka Müller; Lukas P. Frenzel; Clemens-Martin Wendtner; Christian Klein; Pablo Umana; Michael Hallek; Günter Krause

Book ID: 108677011
Publisher: John Wiley and Sons
Year: 2010
Tongue: English
Weight: 297 KB
Volume: 152
Category: Article
ISSN: 0007-1048
DOI: 10.1111/j.1365-2141.2010.08428.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Apoptotic induction by anti-CD20 antibod

Apoptotic induction by anti-CD20 antibodies in chronic lymphocytic leukemia: comparison of rituximab and obinutuzumab

✍ Reslan, Lina; Dalle, Stéphane; Herveau, Stéphanie; Perrial, Emeline; Dumontet, C 📂 Article 📅 2013 🏛 Informa plc 🌐 English ⚖ 384 KB

Successful treatment and re-treatment of

Successful treatment and re-treatment of resistant B-cell chronic lymphocytic leukemia with the monoclonal anti-CD 20 antibody rituximab

✍ M. Herold; A. Schulze; K. Härtwig; G. Anger 📂 Article 📅 2000 🏛 Springer 🌐 English ⚖ 46 KB

Clinical impact of B-cell depletion with

Clinical impact of B-cell depletion with the anti-CD20 antibody rituximab in chronic fatigue syndrome: a preliminary case series

✍ Øystein Fluge; Olav Mella 📂 Article 📅 2009 🏛 BioMed Central 🌐 English ⚖ 252 KB

Reconstitution of the T-cell repertoire

Reconstitution of the T-cell repertoire following treatment with alemtuzumab (anti-CD52 monoclonal antibody) in patients with B-cell chronic lymphocytic leukaemia

✍ Mohammad Reza Rezvany; Mahmood Jeddi Tehrani; Claes Karlsson; Jeanette Lundin; H 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 355 KB

The effect of ranitidine on antibody res

The effect of ranitidine on antibody responses to polysaccharide vaccines in patients with B-cell chronic lymphocytic leukaemia

✍ Ankie M. T. Van der Velden; Heleen Van Velzen-Blad ; Anke M. E. Claessen; René V 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 473 KB

The chimeric anti-CD20 antibody rituxima

The chimeric anti-CD20 antibody rituximab induces apoptosis in B-cell chronic lymphocytic leukemia cells through a p38 mitogen activated protein-kinase-dependent mechanism

✍ Pedersen, I. M. 📂 Article 📅 2002 🏛 American Society of Hematology 🌐 English ⚖ 373 KB